- Contribute to BIA events as appropriate – e.g. UK Bioscience Forum.
- Contribute to international Cell and Gene Therapy events/engagement.
Inform BIA policy work/engagement on:
- The Nagoya Protocol through the BIA Nagoya Cross-Committee Working Group;
- Implementation of the AAR/AAC (Accelerated Access Collaborative);
- Innovate UK issues, including roll-out of NHS treatment centres.
- Develop a plan for contributing to the access and regulatory actions in the Advanced Therapy Manufacturing Taskforce Action Plan, in collaboration with MAC and RAAC.
Committee Chair: Dr Sven Kili, VP and Head of Gene Therapy Development, GSK
For more information contact Rachael Stewart, Policy and Public Affairs Manager
Advanced Centre for Biochemical Engineering, University College London
The Advanced Centre for Biochemical Engineeering hosts the MBI® Modular Training Programme for the Bioindustries.
Asymptote specialises in cryopreservation and liquid nitrogen-free freezers developed for GMP compliant cold chains for regenerative medicine and biobanking.
Autolus is biotechnology company focussed on the development and commercialisation of engineered T-cell therapies for haematological and solid tumours.
Azellon is a spin-out company from The University of Bristol focused on the development and commercialisation of a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair - the Cell Bandage.
Biodivide has the vision to transform the regenerative medicine field by addressing challenges in the complete workflow from stem cell harvest, manufacture, cryostorage to clinical administration.
BioMarin Europe Ltd
BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes
Boult Wade Tennant
Intellectual Property Law firm with expertise in Biotechnology and Life Sciences, Chemical and Materials, Engineering and Designs, High Tech and Electrical and, Trade Mark and Domain Names.
Bristows is a dynamic and globally recognised law firm based in London with a client base that comes from a wide range of industries and includes some of the world’s leading companies.
Cell and Gene Therapy Catapult
The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation.
Cell Medica Ltd
Cell Medica is a clinical cellular therapeutics company engaged in the development, manufacture and marketing of cellular immunotherapy treatments for infectious disease and cancer.
Cellular Therapeutics Ltd
Cellular Therapeutics is focused on “Personalised cellular medicine” using the patient’s own immune system to be harnessed in order to fight disease.
Cobra provides a comprehensive biopharmaceuticals service offering, with multi-functional project teams nurturing products from pre-clinical to commercial scale GMP manufacture.
eXmoor Pharma Concepts Ltd
eXmoor pharma is a technical and strategic consultancy in biopharmaceuticals, secondary pharmaceuticals and cell & gene therapies. We work in capital projects and GMP biomanufacturing.
Field Fisher Waterhouse is a European law firm providing commercial solutions across a range of industry sectors. We have a particular focus on companies that are highly regulated and those with intellectual property and technology driven business models.
GE Healthcare UK Ltd
GE is a global infrastructure, finance and media company taking on the world's toughest challenges.
Gilead Sciences Ltd
Horizon is a revenue-generating life science group supplying research tools to organizations engaged in translational genomics research and the development of personalized medicines.
LGC is an international science-based company and market leader in analytical, forensic, biotechnology, diagnostic and product services and reference standards.
LifeArc is the new name for MRC Technology, a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients.
LIfT Biosciences is bringing a first-in-class innate immuno-oncology therapy to market. The first cell therapy to work in solid tumours.
Lonza Biologics plc
As a worldwide leader supplying the pharmaceutical and biotechnology industries with biopharmaceuticals, Lonza furnishes seven different markets with state-of-the-art products, services, and research.
Miltenyi Biotec Ltd
Moorfields Eye Hospital Biomedical Research Centre
Moorfields Pharmaceuticals is the manufacturing arm of Moorfields Eye Hospital NHS Foundation Trust. We produce nearly 100 ophthalmic specials and have a growing portfolio of branded licensed products.
NHS Blood and Transplant
The Clinical Translation Partnerships (CTP) was established in 2010 to support scientists bringing new cellular therapies into clinical practice.
Oxford BioMedica plc
Oxford BioMedica plc (LSE: OXB) is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs.
Pall Life Sciences
Pall Corporation (NYSE:PLL) is a global leader in the high-tech filtration, separation and purification industry. We’ve become an industry leader by helping a diverse range of customers solve complex fluid management challenges.
Expert global consultancy specialising in access for orphan drugs.
ReNeuron Group Plc
ReNeuron are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Roslin Cell Therapies
Roslin Cells are world leaders in the isolation of new clinical grade pluripotent stem cells for use in research and therapy.
Sarepta Therapeutics is a commercial stage biopharmaceutical company developing RNA targeted and Gene therapies for rare neuromuscular diseases.
TAP Biosystems (TAP) is an innovative UK company providing automation systems and services to improve productivity in life science research, development and production.
Thermo Fisher Scientific